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Abstract
Background Severe burn is a systemic illness often
complicated by sepsis. Kidney is one of the organs invariably
affected, and proteinuria is a constant clinical finding. We
studied the relationships between proteinuria and patient
outcome, severity of renal dysfunction and systemic
inflammatory state in burns patients who developed sepsis-
associated acute renal failure (ARF). We then tested the
hypothesis that plasma in these patients induces apoptosis and
functional alterations that could account for proteinuria and
severity of renal dysfunction in tubular cells and podocytes.
Methods We studied the correlation between proteinuria and
indexes of systemic inflammation or renal function prospectively
in 19 severe burns patients with septic shock and ARF, and we
evaluated the effect of plasma on apoptosis, polarity and
functional alterations in cultured human tubular cells and
podocytes. As controls, we collected plasma from 10 burns
patients with septic shock but without ARF, 10 burns patients
with septic shock and ARF, 10 non-burns patients with septic
shock without ARF, 10 chronic uremic patients and 10 healthy
volunteers.
Results Septic burns patients with ARF presented a severe
proteinuria that correlated to outcome, glomerular (creatinine/
urea clearance) and tubular (fractional excretion of sodium and
potassium) functional impairment and systemic inflammation
(white blood cell (WBC) and platelet counts). Plasma from
these patients induced a pro-apoptotic effect in tubular cells and
podocytes that correlated with the extent of proteinuria. Plasma-
induced apoptosis was significantly higher in septic severe
burns patients with ARF with respect to those without ARF or
with septic shock without burns. Moreover, plasma from septic
burns patients induced an alteration of polarity in tubular cells,
as well as reduced expression of the tight junction protein ZO-1
and of the endocytic receptor megalin. In podocytes, plasma
from septic burns patients increased permeability to albumin
and decreased the expression of the slit diaphragm protein
nephrin.
Conclusion Plasma from burns patients with sepsis-associated
ARF contains factors that affect the function and survival of
tubular cells and podocytes. These factors are likely to be
involved in the pathogenesis of acute tubular injury and
proteinuria, which is a negative prognostic factor and an index of
renal involvement in the systemic inflammatory reaction.
Introduction
Acute renal failure (ARF) is frequently associated with a sys-
temic inflammatory response due to sepsis [1]. Circulating fac-
tors have been proposed as responsible mediators for the
systemic micro-vascular injury occurring in these patients [2].
During sepsis, bacterial endo- or exotoxins can act on
ADQI = Acute Dialysis Quality Initiative; ARF = acute renal failure; BCrC = blood creatinine clerance; BUC = blood urea clearance; FeNa = fractional 
sodium excretion; FeK = fractional potassium excretion; LPS = lipopolysaccharide; Pto/Cro = proteinuria/creatininuria ratio; RRT = renal replacement 
therapy; TER = trans-epithelial resistance; WBC = white blood cells.Critical Care    Vol 12 No 2    Mariano et al.
Page 2 of 12
(page number not for citation purposes)
glomerular podocytes and tubular epithelium, stimulating syn-
thesis of cytokines and other inflammatory mediators [3-6]. In
patients with sepsis-associated ARF, a marked dissociation
between the degree of tubular necrosis and the renal dysfunc-
tion has been described [7]. By contrast, clinical and experi-
mental data suggest that apoptosis plays an important role in
sepsis-induced ARF [4-9].
In severe burns patients, sepsis almost always develops, lasts
for several weeks and is frequently associated with ARF [10-
19]. A constant feature of burn-associated kidney injury is pro-
teinuria, which starts in the first days post-injury and increases
over time. Proteinuria is a consequence of increased glomeru-
lar permeability and of decreased tubular re-absorption of fil-
tered proteins [13,20,21].
Immediately after burn injury, onset of proteinuria can depend
on filtered breakdown proteins derived from massive tissue
destruction or on renal involvement as a consequence of the
increased systemic capillary permeability. Subsequently, pro-
teinuria reflects the involvement of the kidney in the septic
process [13,20-22].
In the present study, we investigated whether circulating fac-
tors present in the plasma of septic severe burns patients
could induce tubular and glomerular alterations that could
account for proteinuria and ARF.
Materials and methods
Patients
From January 2003 to December 2005, from 258 patients
admitted to the Burn Center (Dipartimento di Chirurgia Plas-
tica, Centro Grandi Ustionati, Ospedale CTO, Via G. Zuretti
29, Torino, 10126, Italy) (mean (standard error (SE) burned
surface area 24.5 ± 1.3%, range 1–98%, mortality rate
19.4%), 19 patients with severe burns and septic shock who
developed ARF (8–10 days after burn injury) were enrolled in
a prospective study ("burns septic ARF" group). Demographic
and clinical data (Table 1) for these 19 patients were recorded
and blood and urine biochemical parameters were analyzed.
Plasma samples collected at the time of ARF onset before the
start of renal replacement therapy (RRT) were used for labora-
tory studies. Informed consent was obtained according to the
Declaration of Helsinki and study approval was obtained by
the Center for Molecular Biotechnology Institutional Review
Board, University of Torino.
All 19 patients fulfilled the criteria for septic shock [23] and
ARF according to Acute Dialysis Quality Initiative – Risk, Injury,
Failure, Loss, and End-stage kidney disease (ADQI-RIFLE)
classification [24]. Patients with chronic cardiovascular sys-
tem failure (New York Heart Association (NYHA) class III),
chronic respiratory failure (chronic hypoxia, hypercapnia),
chronic liver failure (biopsy-confirmed cirrhosis or portal hyper-
tension), neoplastic diseases, collagenopathies, insulin-
Table 1
Demographic and clinical characteristics
Septic burns patients with ARF 
(n = 19)
Septic burns patients 
(n = 10)
Septic ARF patients 
(n = 10)
Septic patients 
(n = 10)
Female (n) 7 (36.8%) 2 (20%) 4 (40%) 3 (30%)
Age (years) 50.4 ± 4.6 55.5 ± 6.0 62.4 ± 4.4 58.2 ± 3.8
Burned surface area (%) 51.3 ± 5.4 44.9 ± 6.2 - -
SOFA score (at ARF onset) 11.8 ± 0.4 - 11.7 ± 1.1 -
Non-survivors (n) 10 (52.6%) 8 (80%) 8 (80%) 5 (50%)
Renal replacement therapy (n) 15 (78.9%) - 10 (100%) -
Duration of renal replacement therapy (days) 22.4 ± 2.6 - 12.9 ± 2.7 -
Hemoculture* n (all patients)
Staphylococcus aureus 12
Acinetobacter baumannii 11
Pseudomonas aeruginosa 9
Candida albicans 4
Escherichia coli 1
Klebsiella pneumoniae 1
*All patients had positive blood cultures. Some patients were simultaneously positive for more than one pathogen strain.
Data shows mean ± standard error (SE) unless otherwise stated.
ARF, acute renal failure; SOFA, Sequential Organ Failure Assessment.Available online http://ccforum.com/content/12/2/R42
Page 3 of 12
(page number not for citation purposes)
dependent diabetes mellitus and known aortic aneurysm were
excluded from the study.
As controls, we studied 10 burns patients with septic shock
without ARF ("burns septic" group), 10 septic shock patients
with ARF ("septic ARF" group), 10 patients with septic shock
without ARF ("septic" group), 10 stable uremic patients ("ure-
mic" group) and 10 healthy volunteers ("healthy" group) (Table
1).
Systemic treatment of burns patients was based on current
guidelines and consisted of prompt hydro-electrolytic replace-
ment, ventilatory support when necessary, pain control and
surgical treatment by multiple stage skin excisions and subse-
quent reconstruction by means of autografts or donor allo-
grafts assured by the Regional Skin Bank. Septic events
mainly caused by multiresistant bacterial strains were treated
according to current guidelines with antibiotic regimens fol-
lowing blood cultures and sensitivity tests. When glycopep-
tides or aminoglycosydes were used, the administered dose
was calculated on creatinine clearance and adjusted following
the results of drug blood levels [10].
Biochemical parameters
The clinical observation of the burns septic ARF group was
divided in two periods; the first from burn injury to the onset of
ARF (pre-ARF period) and the second from the onset of ARF
to functional recovery or to exitus (ARF period). Recovery from
ARF was defined as blood creatinine improvement back up to
starting values. The mean times of observation in pre-ARF and
ARF periods were 18.9 ± 3.6 and 19.8 ± 3.8 days, respec-
tively (mean ± SE).
Biochemical evaluation included blood creatinine clearance
(BCrC) and blood urea clearance (BUC) measured by 24-h
diuresis, fractional excretion of sodium (FeNa) and potassium
(FeK), and hemochromocytometer examination.
Proteinuria was determined in an automated analyzer by ben-
zethonium chloride dye binding method (Roche Modular Sys-
tem, Roche Diagnostics GmbH, Mannheim, Germany) [25].
Tumor necrosis factor (TNF)α concentrations in plasma were
measured by Bio-Plex cytokine assay (Biorad, Hercules, CA,
USA).
Laboratory studies
Cells
Podocytes and proximal tubular epithelial primary cultures
were obtained from normal cortex fragments of surgically
removed kidneys. Immortalized tubular cells and podocyte
lines were generated by infection with a hybrid Adeno5/SV40
virus as previously described [26,27].
Viability and apoptosis assays
Cellular viability was studied by using the XTT-based colori-
metric method (Sigma, St Louis, MO, USA).
In all groups studied, apoptosis was evaluated by terminal uri-
dine deoxynucleotidyl transferase dUTP nick-end labeling
(TUNEL) assay (ApopTag, Oncor, Gaithersburg, MD, USA).
Moreover, in selected experiments tubular apoptosis was con-
firmed by identification of intranucleosomal DNA fragmenta-
tion after 1% agarose gel electrophoresis (BioVision Research
Products, Mountain View, CA, USA). The activities of cas-
pases 3, 8 and 9 were assessed by a colorimetric assay
(Chemicon International, Temecula, CA, USA).
Polarity assay
Transepithelial electrical resistance (TER), an indicator of cell
polarity, was measured by using an epithelial volt-ohm meter
(EVOM, World Precision Instruments, Inc., Sarasota, FL, USA)
after incubation of tubular cells or podocytes with different
stimuli. All measures were normalized for the area of the mem-
brane used in the experimental procedure and expressed as
ohm/cm2.
Permeability assay
Permeability was evaluated by diffusion of Trypan blue-albu-
min complexes across podocyte confluent monolayers cul-
tured on Transwell (Greiner Bio-One, Frickenhausen,
Germany) under conditions of continuous slight agitation. Aliq-
uots of medium from the upper and the lower wells were trans-
ferred to a 96-well plate and analyzed at the 590 nm
wavelength (Model 680 Spectrophotometer, Biorad, Her-
cules, CA). Results are given as percentage of increase of
albumin diffusion in comparison to vehicle alone [28].
Gene array
The Human GEarray for the study of apoptosis markers
(Superarray Inc., Bethesda, MD, USA) was performed and
analyzed according to the manufacturer's instructionsto char-
acterize the expression profile of tubular cells incubated in
presence of different plasma samples. These data are freely
available from the ArrayExpress databank of the European Bio-
informatics Institute (experiment name: Human Apoptosis –
Burn; ArrayExpress accession: E-MEXP-1510).
Immunofluorescence, fluorescence-activated cell sorting 
(FACS) and Western blot analysis
For immunofluorescence studies, antibodies directed against
Fas (CD95), CD40 (Upstate, Charlottesville, VA, USA), meg-
alin, ZO-1, E-cadherin and pan-cytokeratins (Santa Cruz Bio-
tech, Santa Cruz, CA, USA) were used with tubular cells. Fas
and CD40 expression were also evaluated by FACS analysis
(Becton Dickinson, Mountain View, CA, USA). Antibodies
directed against nephrin (Progen, Heidelberg, Germany), nes-
tin (Santa Cruz) and ZO-1 were used with podocytes. Specific
Alexa Fluor-conjugated antibodies were used as secondaryCritical Care    Vol 12 No 2    Mariano et al.
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antibodies (Invitrogen, Carlsbad, CA, USA). Fluorescein iso-
thiocyanate (FITC)-conjugated phalloidin (Sigma) was used to
evaluate cytoskeleton actin distribution on tubular cells and
podocytes by ultraviolet (UV) light microscopy.
For Western blot analysis, cell lysates were separated by
SDS-PAGE and immunoblotted with anti-human Bax, anti-
human Bcl-2, anti-human megalin (tubular cells) or anti-human
nephrin (podocytes) antibodies.
Statistical analysis
Descriptive statistics, Student t test, linear regression analysis
with curves of minimal square and analysis of variance
(ANOVA) with Dunnet or Newman-Keuls multi-comparison
test (Statistica 6.1, StaSoft Inc, Tulsa, OK, USA) were per-
formed. Values were expressed as mean ± SE. p Values <
0.05 were considered statistically significant.
Results
Proteinuria was related to patient outcome and systemic 
inflammation
Clinical characteristics of the 19 burns septic ARF group
patients with positive blood cultures are given in Table 1. The
burns septic ARF patients presented marked and persistent
proteinuria (mean ± SE value during 8-week observation
period of 2,074.8 ± 113.4 mg/day). When proteinuria was
expressed as proteinuria/creatininuria ratio (Pto/Cro), a con-
tinuous increase of protein excretion was observed over the
time (Figure 1A). In addition, Pto/Cro was significantly higher
in the ARF period than in the pre-ARF period, and in non-sur-
vivors compared to survivors (Figure 1B).
In the ARF period Pto/Cro significantly correlated in a negative
manner with platelet counts (Figure 1C) and in a positive man-
ner with white blood cell (WBC) counts (Figure 1D). By con-
trast, in the pre-ARF period no significant correlations were
observed between Pto/Cro and platelet (y = 1.9501 +
0.00125, r 0.10041, p 0.27312) or WBC counts (y = 1.8256
+ 0.00004, r 0.10481, p 0.25258).
Proteinuria correlated with loss of glomerular and 
tubular functions
During the ARF period, Pto/Cro negatively correlated both
with decreased BCrC and BUC (Figure 2A,B) and positively
correlated both with FeNa and FeK (Figure 2C,D). The best lin-
ear correlation was observed between Pto/Cro and FeK, with
a Pearson coefficient > 0.6 (Figure 2D). By contrast, in the
pre-ARF period no significant correlations were observed
between Pto/Cro and BCrC, BUC, FeNa and FeK.
Burns septic ARF group plasma exerted a cytotoxic 
effect on tubular cells and on podocytes
Incubation with increasing doses of burns septic ARF group
plasma (range 1–10%) induced a marked reduction of viability
of tubular cells (Figure 3A) and of podocytes (data not shown).
The cytotoxic effect was evident from 12 h, increased over
time and peaked at 48–72 h (data not shown). No significant
cytotoxic effect was observed after addition of control healthy
group plasma.
Burns septic ARF group plasma induced tubular cell 
apoptosis correlated with proteinuria
Consistent with the cytotoxicity data, we observed a signifi-
cant increase of apoptotic tubular cells detected by TUNEL
assay after incubation with lipopolysaccharide (LPS) (positive
control), septic, septic ARF, burns septic and burns septic
ARF group plasma (Figure 3B). The maximal effect was
observed with burns septic ARF group plasma (Figure 3B),
and a similar pro-apoptotic effect was also observed on podo-
cytes (data not shown). Apoptosis was confirmed by detection
of DNA fragmentation (Figure 3B, inset). Since burns patients
were treated with potentially nephrotoxic antibiotics, we used
healthy plasma as control in absence or presence of the same
concentrations of vancomycin (10 μg/ml) and gentamicin (2
μg/ml) detected in the plasma of treated patients. Addition of
antibiotics did not induce a significant increase of tubular
apoptosis (Figure 3B). Furthermore, when we tested plasma
from stable chronic uremic patients, no significant effects
were observed (Figure 3B). The rate of tubular apoptosis
induced by burns septic ARF group plasma significantly corre-
lated with Pto/Cro ratio (Figure 3C).
The apoptotic effect of burns septic ARF group plasma could
be only partially accounted to the presence of LPS. Indeed,
pre-treatment of plasma with polymyxin B significantly
reduced, but did not suppress this effect (Figure 3D), suggest-
ing the presence in plasma of harmful mediator/s other than
LPS. Indeed, the level of TNF-α (81.3 ± 9.4 pg/ml) in these
plasma samples was significantly higher than in healthy con-
trols (5.9 ± 0.8 pg/ml). In addition, pre-incubation of tubular
cells with burns septic ARF group plasma and subsequent
addition of LPS resulted in a significant worsening of tubular
apoptosis in comparison to stimulation with LPS alone (Figure
3D).
The activity of caspases 3, 8 and 9 significantly increased in
tubular cells after incubation with burns septic ARF group
plasma (Figure 4A). Via FACS (Figure 4B–D) and immunoflu-
orescence analysis (Figure 4B–D, insets), we observed a
slight basal expression of Fas (Figure 4B). Fas expression did
not change in the presence of healthy plasma (Figure 4C),
whereas it was markedly up-regulated with burns septic ARF
group plasma (Figure 4D).
In addition, burns septic ARF group plasma, but not control
healthy plasma, induced the up-regulation of Bax and the
down-regulation of Bcl-2 (Figure 4E), proteins known to mod-
ulate the mitochondrial apoptotic pathway. Gene array analy-
sis demonstrated that burns septic ARF group plasma
induced an up-regulation of several pro-apoptotic genes suchAvailable online http://ccforum.com/content/12/2/R42
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as Fas, Fas-Ligand (Fas-L), Bax and Bak and of positive regu-
lators of apoptosis (Abl1, Gadd45a). The negative regulators
of apoptosis, Birc5 and Bnip3, were down-regulated. In addi-
tion, the CD40 gene and its transduction factor TRAF-3, as
well as the nuclear factor (NF)-kB activator Ripk2 gene, were
up-regulated, suggesting an inflammatory activation of tubular
cells (Figure 4F). Up-regulation of CD40 was confirmed by
FACS analysis (Figure 4G). This is consistent with previous
observations indicating that CD40 is over-expressed in renal
tubular epithelial cells during inflammatory injury [29].
Burns septic ARF group plasma altered cytoskeleton 
distribution and megalin expression in tubular cells
Burns septic ARF group plasma induced a marked alteration
of distribution of cytoskeleton actin fibers in tubular cells. In
comparison to control healthy plasma (Figure 5A), burns sep-
tic ARF group plasma promoted the formation of "heaps"
(Figure 5B) composed of tubular cells grouped in clusters, an
effect likewise ascribed to apoptosis.
We then tested whether burns septic ARF group plasma
could induce early alterations in tubular cells not accountable
to apoptosis such as down-regulation of megalin, an endocytic
receptor involved in re-absorption of filtered proteins. Burns
Figure 1
Proteinuria correlates with patient outcome and with markers of systemic inflammation Proteinuria correlates with patient outcome and with markers of systemic inflammation. (a) Proteinuria expressed as proteinuria/creatininuria ratio 
(Pto/Cro, mg/mg) in the weeks following patient admission. Data are given as weekly average of daily values. Only non-oliguric patients were 
included and the number of patients for each week was: week 1, n = 19; week 2, n = 19; week 3, n = 17; week 4, n = 15; week 5, n = 10; week 6, 
n = 7; week 7, n = 6; week 8, n = 5. (b) Overall mean proteinuria in pre-acute renal failure (ARF) vs ARF periods and in deceased vs surviving 
patients. (c, d) Relationship between Pto/Cro and indexes of systemic inflammatory state in ARF period. Pto/Cro negatively correlated with platelet 
count (c) and positively with white blood cell (WBC) count (d). Student t test and linear regression analysis were performed where appropriate. 
Data for different parameters are also shown as minimal square fitting curves.Critical Care    Vol 12 No 2    Mariano et al.
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septic ARF group plasma provoked a marked down-regulation
of megalin (Figure 5D–E). By contrast, control healthy plasma
did not alter the normal expression pattern of megalin (Figure
5C–E).
Burns septic ARF group plasma altered tubular cell 
polarity
The loss of polarity of tubular cells was studied by evaluating
TER. After incubation with burns septic ARF group plasma,
tubular cells exhibited significantly lower TER values in com-
parison to healthy controls (Figure 5F). Burns septic ARF
group plasma also induced a decreased expression of E-cad-
herin and pan-cytokeratin epithelial markers (data not shown)
and of the tight junction protein ZO-1 (Figure 5G–I).
Burns septic ARF group plasma altered polarity, 
cytoskeleton distribution, permeability and nephrin 
expression in podocytes
After incubation with burns septic ARF group plasma, podo-
cytes exhibited significantly lower TER values in comparison
with healthy controls (Figure 6A). Burns septic ARF group
plasma also induced a marked redistribution of actin fibers
(data not shown) and of the intermediate filament protein nes-
tin (Figure 6B–D). Nestin filaments appeared concentrated
under the plasma membrane (Figure 6D), when compared
with the diffuse cellular staining of controls (Figure 6B–C).
Burns septic ARF group plasma led to a significant average
increase of albumin diffusion in comparison to healthy controls
(Figure 6E). The expression of nephrin, a slit diaphragm pro-
tein, whose alteration is deeply involved in the pathogenic
mechanisms of proteinuria, was also investigated. In the pres-
ence of vehicle alone (Figure 6F) or control healthy plasma
(Figure 6G), podocytes showed a positive diffuse staining for
nephrin that was almost completely abrogated after incubation
with burns septic ARF group plasma (Figure 6H). These
results were confirmed by Western blot analysis (Figure 6I).
Discussion
In the present study we demonstrate that plasma from patients
with severe burns and sepsis-associated ARF contains factors
that induce functional alterations in tubular cells and podo-
Figure 2
Correlation among proteinuria and indexes of glomerular and tubular function in acute renal failure (ARF) period Correlation among proteinuria and indexes of glomerular and tubular function in acute renal failure (ARF) period. (a, b) Significant negative relation-
ship between proteinuria/creatininuria ratio (Pto/Cro, mg/mg) and blood creatinine clearance (BCrC, ml/min, (a)) and blood urea clearance (BUC, 
ml/min, (b)). (c, d) Significant positive relationship between Pto/Cro and fractional excretion of sodium (FeNa, (c)) and potassium (FeK, (d)). A sta-
tistical linear regression test analysis was performed. Data for different parameters are also shown as minimal square fitting curves.Available online http://ccforum.com/content/12/2/R42
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cytes. Plasma-induced apoptosis on tubular cells correlated
with the extent of proteinuria, which in turn was related to the
severity of the septic process, with impairment of renal func-
tion, and with patient outcome.
We found that proteinuria, expressed as Pto/Cro ratio in order
to avoid the tubular concentration factor, progressively
increased after the onset of ARF and was higher in non-survi-
vors than in survivors, as recently reported [30]. We also
observed that proteinuria in the ARF period was inversely cor-
related with BCrC and BUC and directly with FeNa and FeK.
These correlations suggest that, at least in this group of
patients, proteinuria is a reliable index of the severity of glomer-
ular and tubular injury.
In the ARF period, proteinuria significantly correlated with
platelet and WBC counts, which are activated during sepsis
[31-33].
In burns patients with sepsis and ARF, the mechanisms of late
and sustained glomerular and tubular injury are complex,
involving hemodynamic changes, tissue breakdown products,
development of septicemia and drug nephrotoxicity [10-13].
In the present study, we found that sepsis was a determinant
factor for the induction of apoptotic injury of kidney cells.
Indeed, plasma from burns patients with sepsis-associated
ARF exerted an enhanced pro-apoptotic effect on tubular
cells, suggesting that burns and ARF could be linked in wors-
Figure 3
Pro-apoptotic effect of burns septic acute renal failure (ARF) group plasma on tubular cells and correlation with proteinuria Pro-apoptotic effect of burns septic acute renal failure (ARF) group plasma on tubular cells and correlation with proteinuria. (a) Plasma from burns 
septic ARF group patients induced a dose-dependent decrease of tubular cell viability (XTT-based assay, n = 19, *p < 0.05 burns septic ARF group 
plasma 2.5%, 5% or 10% vs control healthy plasma). (b) Burns septic ARF group plasma (5%, 48 h of incubation, n = 19) induced a significant 
increase in tubular apoptosis (terminal uridine deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay, *p < 0.05 burns septic ARF 
group plasma vs control healthy plasma, healthy plasma + gentamicin, healthy plasma + vancomycin or uremic plasma). Gentamicin (2 μg/ml) or van-
comycin (10 μg/ml) was added to control healthy plasma in selected experiments (n = 10). A significant increase of tubular apoptosis with a maximal 
effect with burns septic ARF group plasma (*p < 0.05 septic, septic ARF or burns septic vs all controls) was observed. LPS (30 ng/ml) was used as 
positive experimental control. (b) inset, typical DNA fragmentation of apoptotic tubular cells (burns septic ARF group plasma in lanes 1–4, positive 
control 30 ng/ml LPS in lane 6, negative control healthy plasma in lane 5). (c) Correlation between the percentage of tubular apoptosis induced by 
burns septic ARF group plasma (TUNEL assay) and Pto/Cro of the enrolled patients (n = 19). (d) Significant reduction of tubular apoptosis (TUNEL 
assay) after addition of 5 μg/ml polymyxin B (#p < 0.05 burns septic ARF group + polymyxin vs burns septic ARF group, n = 19). Lipopolysaccharide 
(LPS; 30 ng/ml) was used as internal control. Polymyxin B pre-treatment did not completely suppress plasma-induced apoptosis (*p < 0.05 burns 
septic ARF group + polymyxin vs control healthy plasma). Burns septic ARF group plasma but not control healthy plasma enhanced LPS-induced 
tubular apoptosis (§p < 0.05 burns septic ARF group plasma + LPS vs control healthy plasma + LPS). Values in (a), (b) and (d) are expressed as 
averages ± standard error (SE). Each plasma was tested in triplicate. Analysis of variance (ANOVA) with Newman-Keuls multi-comparison test was 
performed. Linear regression analysis was performed in (c).Critical Care    Vol 12 No 2    Mariano et al.
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Figure 4
Burns septic ARF group plasma activated caspases, up-regulated Fas/CD40 and modulated Bax/Bcl-2 in tubular cells Burns septic ARF group plasma activated caspases, up-regulated Fas/CD40 and modulated Bax/Bcl-2 in tubular cells. (a) Significant increased 
activities of caspases 3, 8 and 9 on tubular cells incubated for 48 h with burns septic acute renal failure (ARF) group plasma (n = 19) in comparison 
to control healthy plasma (n = 10). All plasma samples were tested in triplicate. Student t test was performed: (p < 0.05 *caspase-3, §caspase-8 
and #caspase-9 activities of burns septic ARF group vs control healthy plasma). (b-d) Representative images of fluorescence-activated cell sorting 
(FACS) and immunofluorescence (insets) analysis of Fas (CD95) expression on tubular cell surface after exposure to different stimuli. With respect 
to vehicle alone (b) or control healthy plasma (c), burns septic ARF group plasma induced a marked up-regulation of Fas (d) (magnification × 400, 
nuclei counterstained with 1 μg/ml propidium iodide). Similar results were obtained with all tested plasma. (e) Up-regulation of the pro-apoptotic 
protein Bax and down-regulation of the antiapoptotic protein Bcl-2 in representative Western blot analysis on lysates of tubular cells (vehicle alone in 
lane 1, control healthy plasma in lanes 2–5, burns septic ARF group plasma in lanes 6–9) and related densitometric analysis. Beta-actin was used as 
reference for protein loading. (f) Percentage variation of expression of genes involved in apoptosis of tubular cells exposed to burns septic ARF 
group plasma. Tubular cells showed an increased expression of genes related to receptor-mediated (Fas, Fas-Ligand) and mitochondrial apoptotic 
pathways (Bax, Bak), of the co-stimulatory molecule CD40, of the CD40-transducer protein TRAF-3 and of the positive regulator of nuclear factor 
(NF)-κB activator RIPK2. Results are given as ratio between densitometric analyses of gene expression in tubular cells exposed to burns septic ARF 
group plasma with respect to control healthy plasma. House-keeping genes (beta-actin, GAPDH) were used as reference for densitometric analysis. 
Three experiments were performed with similar results. These data are feely available from the ArrayExpress databank of the European Bioinformat-
ics Institute (see Materials and methods). Representative FACS analysis of CD40 expression was performed on unstimulated tubular cells (Vehicle), 
or in the presence of control healthy plasma, or burns septic ARF group plasma. Similar results were obtained with all tested burns septic ARF group 
plasma. The grey areas show the isotypic control.Available online http://ccforum.com/content/12/2/R42
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ening sepsis-induced apoptosis [4-6,34]. The apoptotic activ-
ity of plasma was also found to correlate with Pto/Cro.
Previous studies suggested a link among sepsis, plasma con-
centrations of pro-apoptotic molecules and kidney injury. In
vitro, LPS and inflammatory cytokines promoted tubular cell
apoptosis by up-regulating Fas expression and caspase activ-
ity [9]. In clinical studies in burns patients, plasma soluble Fas
levels were found to be significantly higher in non-survivors
than in survivors [35].
Here, we show that burns septic ARF group plasma induced
both activation of caspases and up-regulation of Fas on tubu-
lar cells. Our data suggest an involvement of both Fas death-
receptor and mitochondrial tubular apoptotic pathways.
Indeed, we observed a down-regulation of the anti-apoptotic
protein Bcl-2 and an up-regulation of the pro-apoptotic protein
Bax. These results are consistent with data observed in exper-
imental animals injected with LPS [36-38].
Moreover, burns septic ARF group plasma significantly
enhanced tubular apoptosis induced by LPS. In these
patients, plasmatic peaks of LPS can induce direct renal dam-
age and can also stimulate further production of inflammatory
mediators [5-9]. We found that the effect of burns septic ARF
group plasma on tubular apoptosis was partially inhibited, but
not suppressed, by LPS blockade, suggesting that mediators
other than LPS contributed to such phenomenon. In our exper-
imental setting, we found enhanced levels of TNFα, which is
known to induce tubular apoptosis. Moreover, the high serum
levels of a broad range of cytokines detected in these patients
[34] suggest the involvement of multiple mediators in specific
organ injury [8,9,39].
Figure 5
Burns septic acute renal failure (ARF) group plasma altered cytoskeleton, megalin and tight junction expression and polarity in tubular cells Burns septic acute renal failure (ARF) group plasma altered cytoskeleton, megalin and tight junction expression and polarity in tubular cells. (a, b) 
Representative micrographs showing normal distribution ((a) control healthy plasma) and marked re-arrangement of cytoskeleton actin on tubular 
cells exposed for 48 h to burns septic ARF group plasma (b) with formation of "heaps" (white arrows) visible via ultraviolet (UV) light microscopy 
after staining with fluorescein isothiocyanate (FITC)-conjugated phalloidin (magnification × 100). (c, d) Representative immunofluorescence of meg-
alin expression on tubular cells incubated with control healthy plasma (c) and its down-regulation in presence of burns septic ARF group plasma (d) 
(magnification × 400, nuclei counterstained with 1 μg/ml propidium iodide). Similar results were observed with all tested plasma samples. (e) Rep-
resentative Western blot analysis of megalin expression on tubular cells (vehicle alone in lane 1, control healthy plasma in lanes 2–5, burns septic 
ARF group plasma in lanes 6–9) and densitometric analysis. Beta-actin was used as reference for protein loading. (f) Significant loss of polarity of 
tubular cells evaluated by the decrease of trans-epithelial resistance (TER) normalized for the membrane area after incubation with burns septic ARF 
group plasma for 12 h (*p < 0.05 burns septic ARF group vs control healthy plasma). (g-i) Representative micrographs showing the expression of 
the tight junction protein ZO-1 on unstimulated tubular cells (g), in the presence of control healthy plasma (h) and its down-regulation after incuba-
tion with burns septic ARF group plasma (i) (magnification × 400, nuclei counterstained with 1 μg/ml propidium iodide). Similar results were 
obtained with all tested plasma samples. Values in (f) are expressed as averages ± standard error (SE). Each plasma sample was tested in triplicate. 
Analysis of variance (ANOVA) with Newman-Keuls multi-comparison test was performed.Critical Care    Vol 12 No 2    Mariano et al.
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In the first weeks after burn injury, proteinuria is usually in the
nephrotic range with a mixed glomerular and tubular pattern
[13], suggesting a simultaneous defect of tubular re-absorp-
tion and an increase of glomerular permeability. Megalin is an
endocytic receptor that plays a pivotal role in the normal re-
absorption of filtered proteins [40]. Burns septic ARF group
plasma induced a significant decrease of megalin expression
on tubular cells, suggesting that the impairment of tubular re-
adsorption due either to apoptosis or to loss of megalin
expression could contribute to proteinuria, resulting in the fail-
ure of tubular handling of filtered proteins.
We also observed a marked down-regulation of nephrin
expression in cultured podocytes after exposure to burns sep-
tic ARF group plasma. Nephrin is a protein of the slit dia-
phragm of podocytes that regulates glomerular permeability.
Figure 6
Burns septic acute renal failure (ARF) group plasma altered polarity, permeability to albumin and nephrin expression on podocytes Burns septic acute renal failure (ARF) group plasma altered polarity, permeability to albumin and nephrin expression on podocytes. (a) Significant 
variation of trans-epithelial resistance (TER) after exposure to burns septic ARF group plasma (*p < 0.05 burns septic ARF group vs control healthy 
plasma). (b-d) Representative immunofluorescence images of the altered distribution of the intermediate filament protein nestin in presence of burns 
septic plasma (d), not detectable after incubation with vehicle alone (b) or control healthy plasma (c) (magnification × 400, nuclei counterstained 
with 1 μg/ml propidium iodide). After burns septic plasma challenge, nestin lost its typical diffuse distribution and was localized in the sub-membrane 
spaces forming several "rings" (d). (e) Significant increased diffusion of albumin across podocyte monolayers exposed to burns septic ARF group 
plasma (*p < 0.05 burns septic plasma vs control healthy plasma). (f-h) Representative immunofluorescence images of the slit diaphragm protein 
nephrin after exposure to vehicle alone (f), control healthy plasma (g) and burns septic ARF group plasma (h). Burns septic ARF group plasma 
induced a diffuse loss of nephrin (magnification × 400, nuclei counterstained with 1 μg/ml propidium iodide). (i) Representative Western blot analy-
sis of podocyte nephrin expression (vehicle alone in lane 1, control healthy plasma in lanes 2–5, burns septic ARF group plasma in lanes 6–9) and 
related densitometric analysis. Beta-actin was used as reference for protein loading. Values in (a) and (e) are expressed as averages ± standard 
error (SE). Each plasma was tested in triplicate. Analysis of variance (ANOVA) with Newman-Keuls multi-comparison test was performed.Available online http://ccforum.com/content/12/2/R42
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Its redistribution and loss has been shown to occur in patients
with congenital or acquired nephrotic syndrome [41,42]. In
addition, we observed a redistribution of actin cytoskeleton fib-
ers and of the intermediate filament protein nestin. Nestin is
able to stably link the intermediate filaments to other cytoskel-
eton proteins, playing a role in the correct organization and
function of podocytes [43]. The alterations in nephrin and
cytoskeleton distribution might also account for the altered
cell polarity and albumin transport across the podocyte
monolayer observed after challenge with burns septic ARF
group plasma.
In this clinical setting, several other tubular abnormalities
including increased fractional sodium excretion and uric acid
clearance, low threshold of phosphate adsorption, glycosuria
and aminoaciduria have been described [11-13,20]. We
found a significant correlation between proteinuria and urine
loss of sodium (r = 0.46) and potassium (r = 0.60). Physiolog-
ical tubular handling of electrolytes is based on the mainte-
nance of cell polarity and on the integrity of tight junction
protein expression [44]. After challenge of tubular cells with
burns septic ARF group plasma, we observed a marked
decrease of ZO-1 expression with a simultaneous alteration of
TER. These functional changes could alter the ability of tubular
cells in maintaining compositionally distinct fluid-filled com-
partments with precise electrolyte concentrations.
Conclusion
The results of the present study demonstrate that plasma sam-
ples from septic patients with severe burns contain pro-apop-
totic factors that could contribute to the development of renal
injury and proteinuria. These findings provide a further ration-
ale for ongoing clinical studies aimed at the use of drugs that
inhibit apoptosis [45] and therapeutic removal of inflammatory
mediators by extracorporeal techniques [46]. Strategies
aimed at increasing the removal of cytokines from the circula-
tion could prevent the onset of ARF and improve the clinical
outcome for these patients [46].
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